Skip to main content Accessibility help
×
×
Home
  • Print publication year: 2017
  • Online publication date: June 2017

4 - Neurobiology of Disaster Exposure

from Part II - Foundations of Disaster Psychiatry
Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Textbook of Disaster Psychiatry
  • Online ISBN: 9781316481424
  • Book DOI: https://doi.org/10.1017/9781316481424
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×
Admon, R., Milad, M. R., & Hendler, T. (2013). A causal model of post-traumatic stress disorder: Disentangling predisposed from acquired neural abnormalities. Trends in Cognitive Sciences, 17, 337347.
Amos, T., Stein, D. J., & Ipser, J. C. (2014). Pharmacological interventions for preventing post-traumatic stress disorder (PTSD). Cochrane Database of Systematic Reviews, 8, Cd006239.
Ashley-Koch, A. E., Garrett, M. E., Gibson, J., Liu, Y., Dennis, M. F., Kimbrel, N. A. et al. (2015). Genome-wide association study of posttraumatic stress disorder in a cohort of Iraq-Afghanistan era veterans. Journal of Affective Disordors, 184, 225234.
Barsaglini, A., Sartori, G., Benetti, S., Pettersson-Yeo, W., & Mechelli, A. (2014). The effects of psychotherapy on brain function: A systematic and critical review. Progress in Neurobiology, 114, 114.
Boccia, M., D’Amico, S., Bianchini, F., Marano, A., Giannini, A. M., & Piccardi, L. (2016). Different neural modifications underpin PTSD after different traumatic events: An fMRI meta-analytic study. Brain Imaging and Behavior, 10, 226237.
Bremner, J. D., Randall, P., Scott, T. M., Bronen, R. A., Seibyl, J. P., Southwick, S. M. et al. (1995). MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. American Journal of Psychiatry, 152, 973981.
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H. et al. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science, 301, 386389.
Chen, Y., Rex, C. S., Rice, C. J., Dube, C. M., Gall, C. M., Lynch, G. et al. (2010). Correlated memory defects and hippocampal dendritic spine loss after acute stress involve corticotropin-releasing hormone signaling. Proceedings of the National Academy of Sciences, 107, 1312313128.
Daniels, J. K., Frewen, P., Theberge, J., & Lanius, R. A. (2016). Structural brain aberrations associated with the dissociative subtype of post-traumatic stress disorder. Acta Psychiatrica Scandinavia, 133, 232240.
Denson, T. F., Pedersen, W. C., Ronquillo, J., & Nandy, A. S. (2009). The angry brain: Neural correlates of anger, angry rumination, and aggressive personality. Journal of Cognitive Neuroscience, 21, 734744.
Department of Veterans Affairs/Department of Defense (2010). VA/DoD clinical practice guideline for the management of posttraumatic stress, version 2.0. Washington, DC: Veterans Health Administration, Department of Defense.
Enman, N. M., Sabban, E. L., McGonigle, P., & Van Bockstaele, E. J. (2015). Targeting the neuropeptide Y system in stress-related psychiatric disorders. Neurobiology of Stress, 1, 3343.
Feder, A., Parides, M. K., Murrough, J. W., Perez, A. M., Morgan, J. E., Saxena, S. et al. (2014). Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: A randomized clinical trial. JAMA Psychiatry, 71, 681688.
Fitzgerald, P. J., Giustino, T. F., Seemann, J. R., & Maren, S. (2015). Noradrenergic blockade stabilizes prefrontal activity and enables fear extinction under stress. Proceedings of the National Academy of Sciences, 112, E3729E3737.
Fletcher, S., Creamer, M., & Forbes, D. (2010). Preventing post traumatic stress disorder: Are drugs the answer? Australian and New Zealand Journal of Psychiatry, 44, 10641071.
Freedman, S. A., Brandes, D., Peri, T., & Shalev, A. (1999). Predictors of chronic post-traumatic stress disorder: A prospective study. British Journal of Psychiatry, 174, 353359.
Friedman, M. J., & Davidson, J. R. T. (2014). Pharmacotherapy for PTSD. In Friedman, M. J., Keane, T. M., & Resick, P. A. (Eds.), Handbook of PTSD: Science and practice, second edition (pp. 482501). New York: Guilford Press.
Galatzer-Levy, I. R., Steenkamp, M. M., Brown, A. D., Qian, M., Inslicht, S., Henn-Haase, C. et al. (2014). Cortisol response to an experimental stress paradigm prospectively predicts long-term distress and resilience trajectories in response to active police service. Journal of Psychiatric Research, 56, 3642.
Highland, K. B., Costanzo, M. E., Jovanovic, T., Norrholm, S. D., Ndiongue, R. B., Reinhardt, B. J. et al. (2015). Catecholamine responses to virtual combat: Implications for post-traumatic stress and dimensions of functioning. Frontiers in Psychology, 6, 256.
Honsberger, M. J., Taylor, J. R., & Corlett, P. R. (2015). Memories reactivated under ketamine are subsequently stronger: A potential pre-clinical behavioral model of psychosis. Schizophrenia Research, 164, 227233.
Inslicht, S. S., Otte, C., McCaslin, S. E., Apfel, B. A., Henn-Haase, C., Metzler, T. et al. (2011). Cortisol awakening response prospectively predicts peritraumatic and acute stress reactions in police officers. Biological Psychiatry, 70, 10551062.
Jetly, R., Heber, A., Fraser, G., & Boisvert, D. (2015). The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study. Psychoneuroendocrinology, 51, 585588.
Kassem, M. S., Lagopoulos, J., Stait-Gardner, T., Price, W. S., Chohan, T. W., Arnold, J. C. et al. (2013). Stress-induced grey matter loss determined by MRI is primarily due to loss of dendrites and their synapses. Molecular Neurobiology, 47, 645661.
Kaufman, J., Yang, B. Z., Douglas-Palumberi, H., Houshyar, S., Lipschitz, D., Krystal, J. H. et al. (2004). Social supports and serotonin transporter gene moderate depression in maltreated children. Proceedings of the National Academy of Sciences, 101, 1731617321.
Kim, T. Y., Chung, H. G., Shin, H. S., Kim, S. J., Choi, J. H., Chung, M. Y. et al. (2013). Apolipoprotein E gene polymorphism, alcohol use, and their interactions in combat-related posttraumatic stress disorder. Depression and Anxiety, 30, 11941201.
Krystal, J. H., & Neumeister, A. (2009). Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience. Brain Research, 1293, 1323.
Lanius, R. A., Vermetten, E., Loewenstein, R. J., Brand, B., Schmahl, C., Bremner, J. D. et al. (2010). Emotion modulation in PTSD: Clinical and neurobiological evidence for a dissociative subtype. American Journal of Psychiatry, 167, 640647.
LeDoux, J. E. (2014). Coming to terms with fear. Proceedings of the National Academy of Sciences, 111, 28712878.
Liberzon, I., & Sripada, C. S. (2008). The functional neuroanatomy of PTSD: A critical review. Progressive Brain Research, 167, 151169.
Murrough, J. W., Henry, S., Hu, J., Gallezot, J. D., Planeta-Wilson, B., Neumaier, J. F. et al. (2011). Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder. Psychopharmacology, 213, 547553.
Nash, M., Galatzer-Levy, I., Krystal, J. H., Duman, R., & Neumeister, A. (2014). Neurocircuitry and neuroplasticity in PTSD. In Friedman, M. J., Keane, T. M., & Resick, P. A. (Eds.), Handbook of PTSD: Science and practice (2nd ed., pp. 251274). New York: Guilford Press.
O’Doherty, D. C., Chitty, K. M., Saddiqui, S., Bennett, M. R., & Lagopoulos, J. (2015). A systematic review and meta-analysis of magnetic resonance imaging measurement of structural volumes in posttraumatic stress disorder. Psychiatry Research, 232, 133.
Pervanidou, P., & Chrousos, G. P. (2010). Neuroendocrinology of post-traumatic stress disorder. Progress in Brain Research, 182, 149160.
Petrakis, I. L., Desai, N., Gueorguieva, R., Arias, A., O’Brien, E., Jane, J. S. et al. (2016). Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: A clinical trial. Alcoholism, Clinical and Experimental Research, 40, 178186.
Pietrzak, R. H., Henry, S., Southwick, S. M., Krystal, J. H., & Neumeister, A. (2013). Linking in vivo brain serotonin type 1B receptor density to phenotypic heterogeneity of posttraumatic stress symptomatology. Molecular Psychiatry, 18, 399401.
Pietrzak, R. H., Huang, Y., Corsi-Travali, S., Zheng, M. Q., Lin, S. F., Henry, S. et al. (2014a). Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors. Neuropsychopharmacology, 39, 25192528.
Pietrzak, R. H., Naganawa, M., Huang, Y., Corsi-Travali, S., Zheng, M. Q., Stein, M. B. et al. (2014b). Association of in vivo kappa-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology. JAMA Psychiatry, 71, 12621270.
Pitman, R. K., Rasmusson, A. M., Koenen, K. C., Shin, L. M., Orr, S. P., Gilbertson, M. W. et al. (2012). Biological studies of post-traumatic stress disorder. Nature Reviews. Neuroscience, 13, 769787.
Pole, N. (2007). The psychophysiology of posttraumatic stress disorder: A meta-analysis. Psychological Bulletin, 133, 725746.
Ragen, B. J., Seidel, J., Chollak, C., Pietrzak, R. H., & Neumeister, A. (2015). Investigational drugs under development for the treatment of PTSD. Expert Opinion on Investigational Drugs, 24, 659672.
Raskind, M. A., Peterson, K., Williams, T., Hoff, D. J., Hart, K., Holmes, H. et al. (2013). A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. American Journal of Psychiatry, 170, 10031010.
Ravindran, L. N., & Stein, M. B. (2009). Pharmacotherapy of PTSD: Premises, principles, and priorities. Brain Research, 1293, 2439.
Sabban, E. L., Alaluf, L. G., & Serova, L. I. (2016). Potential of neuropeptide Y for preventing or treating post-traumatic stress disorder. Neuropeptides, 56, 1924.
Schiller, D., Monfils, M. H., Raio, C. M., Johnson, D. C., Ledoux, J. E., & Phelps, E. A. (2010). Preventing the return of fear in humans using reconsolidation update mechanisms. Nature, 463, 4953.
Seedat, S., Stein, D. J., & Carey, P. D. (2005). Post-traumatic stress disorder in women: Epidemiological and treatment issues. CNS Drugs, 19, 411427.
Sergio Tde, O., Spiacci, Jr., A., & Zangrossi, Jr., H. (2014). Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic. Psychoneuroendocrinology, 49, 321330.
Simpson, T. L., Malte, C. A., Dietel, B., Tell, D., Pocock, I., Lyons, R. et al. (2015). A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder. Alcoholism, Clinical and Experimental Research, 39, 808817.
Smith, R. P., Katz, C. L., Charney, D. S., & Southwick, S. M. (2007). Neurobiology of disaster exposure: Fear, anxiety, trauma, and resilience. In Ursano, R. J., Fullerton, C. S., Weisaeth, L., & Raphael, B. (Eds.), Textbook of Disaster Psychiatry (pp. 97117). Cambridge: Cambridge University Press.
Southwick, S. M., Morgan, III, C. A., Charney, D. S., & High, J. R. (1999). Yohimbine use in a natural setting: Effects on posttraumatic stress disorder. Biological Psychiatry, 46, 442444.
Stark, E. A., Parsons, C. E., Van Hartevelt, T. J., Charquero-Ballester, M., McManners, H., Ehlers, A. et al. (2015). Post-traumatic stress influences the brain even in the absence of symptoms: A systematic, quantitative meta-analysis of neuroimaging studies. Neuroscience and Biobehavioral Reviews, 56, 207221.
Steenen, S. A., van Wijk, A. J., van der Heijden, G. J., van Westrhenen, R., de Lange, J., & de Jongh, A. (2016). Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis. Journal of Psychopharmacology, 30, 128139.
Suliman, S., Seedat, S., Pingo, J., Sutherland, T., Zohar, J., & Stein, D. J. (2015). Escitalopram in the prevention of posttraumatic stress disorder: A pilot randomized controlled trial. BMC Psychiatry, 15, 24.
Wingenfeld, K., Whooley, M. A., Neylan, T. C., Otte, C., & Cohen, B. E. (2015). Effect of current and lifetime posttraumatic stress disorder on 24-h urinary catecholamines and cortisol: Results from the Mind Your Heart Study. Psychoneuroendocrinology, 52, 8391.
Wolf, E. J., Mitchell, K. S., Koenen, K. C., & Miller, M. W. (2014). Combat exposure severity as a moderator of genetic and environmental liability to post-traumatic stress disorder. Psychological Medicine, 44, 14991509.
Wood, N. E., Rosasco, M. L., Suris, A. M., Spring, J. D., Marin, M. F., Lasko, N. B. et al. (2015). Pharmacological blockade of memory reconsolidation in posttraumatic stress disorder: Three negative psychophysiological studies. Psychiatry Research, 225, 3139.
Wu, G., Feder, A., Cohen, H., Kim, J. J., Calderon, S., Charney, D. S. et al. (2013). Understanding resilience. Frontiers in Behavioral Neuroscience, 7, 10.
Yehuda, R., Golier, J. A., Bierer, L. M., Mikhno, A., Pratchett, L. C., Burton, C. L. et al. (2010). Hydrocortisone responsiveness in Gulf War veterans with PTSD: Effects on ACTH, declarative memory hippocampal [(18)F]FDG uptake on PET. Psychiatry Research, 184, 117127.
Yehuda, R., Koenen, K. C., Galea, S., & Flory, J. D. (2011). The role of genes in defining a molecular biology of PTSD. Disease Markers, 30, 6776.
Zohar, J., Yahalom, H., Kozlovsky, N., Cwikel-Hamzany, S., Matar, M. A., Kaplan, Z. et al. (2011). High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: Interplay between clinical and animal studies. European Neuropsychopharmacology, 21, 796809.
Zovkic, I. B., & Sweatt, J. D. (2013). Epigenetic mechanisms in learned fear: Implications for PTSD. Neuropsychopharmacology, 38, 7793.